A once-in-a-decade opportunity to buy these ASX 200 growth shares before they rocket?

Is now the time to seize on market weakness to buy these highly rated stocks?

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think it is fair to say that the past few weeks have been difficult for investors. Particularly those that invest in ASX 200 growth shares.

The dramatic selloff has seen many shares retreating sharply from their recent highs.

While it is disappointing to see your portfolio shed value, every cloud has a silver lining.

The silver lining here is that it could have created a once-in-a-decade opportunity that investors have been waiting for – a chance to buy quality ASX 200 growth shares at a discount before they rebound and potentially rocket to new highs.

But which growth shares could be worth buying right now? Let's take a look at three that analysts are tipping as buys. They are as follows:

Lovisa Holdings Ltd (ASX: LOV)

The first ASX 200 growth share to consider buying after the selloff is Lovisa. This fashion jewellery retailer's shares have pulled back by over 7% from recent highs.

Analysts at Morgans will see this as a buying opportunity. Following a similar pullback at the end of last year, the broker commented: "Lovisa has proven it can successfully build out its unique brand in many diverse territories around the world on its journey to becoming a truly global brand. It's at times like these that investors should be getting set to reap the rewards of this strategy over the longer term."

Morgans has an add rating and $37.00 price target on its shares.

Pro Medicus Limited (ASX: PME)

Another ASX 200 growth share that was dragged lower during the market selloff is Pro Medicus. It is a leading provider of radiology information systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualisation solutions across the globe.

Analysts at Goldman Sachs are likely to see this pullback as a great opportunity for investors to buy this high quality company. Particularly given how the broker sees "PME as the clear incumbent technology leader in a growing market with a strong financial profile and significant AI upside."

It has a buy rating and $148.00 price target on its shares.

Xero Ltd (ASX: XRO)

A final stock that could be a top option for investors is Xero. This leading cloud-based accounting software provider is another ASX 200 growth share that has been caught up in the recent selloff.

However, despite the near-term volatility, Xero's long-term growth prospects remain very bright thanks to the structural shift to the cloud. In fact, Goldman Sachs estimates that it has a total addressable market of 100 million small to medium sized businesses. This compares to its current subscriber base of 4.2 million.

Goldman believes this gives it a multi-decade growth runway. It is no surprise then that it is tipping its shares as a buy with a $180.00 price target.

Motley Fool contributor James Mickleboro has positions in Lovisa, Pro Medicus, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Lovisa, Pro Medicus, and Xero. The Motley Fool Australia has positions in and has recommended Xero. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A group of businesspeople clapping.
Growth Shares

Here are 2 of the best ASX 200 growth shares to buy now

Analysts think these growth stocks could be high quality picks.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Growth Shares

Up 30% in a month, I think this ASX 300 share is still a long-term buy

This stock is a very exciting prospect in my opinion.

Read more »

A young boy sits on his father's shoulders as they flex their muscles at sunrise on a beach
Growth Shares

2 ASX growth shares I bought in this week's volatility

The lower prices of these stocks were too good for me to ignore.

Read more »

drone stuck in a tree representing crashing Aerometrix share price
Growth Shares

After its share price crashed 58% in a month, is this a bargain basement ASX growth stock?

While it comes with added risks, I think this ASX growth stock offers the potential for supersized share price gains.

Read more »

A cloud with a blue arrow pointing upwards through its middle symbolising a rising asx share price
Broker Notes

4 ASX 200 stocks tipped to deliver 40% to 160% EPS growth in FY25

Broker Macquarie thinks these companies can deliver the goods despite a challenging economy in FY25.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Experts say these fantastic ASX growth shares are strong buys

Analysts have just put buy ratings on these stocks.

Read more »

A young woman's hands are shown close up with many blingy gold rings on her fingers and two large gold chains around her neck with dollar signs on them.
Growth Shares

Analysts expect big earnings jumps from these ASX 200 growth stocks

The international potential of these stocks is excellent.

Read more »

A happy young girls lies in the grass with her father, smiling at the prospects of a bright future.
Growth Shares

Top ASX growth shares to consider buying in August

These two names are primed to grow, according to brokers.

Read more »